+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Skin Cancer Drugs Market Research Reports

From
Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

  • Report
  • January 2023
  • 184 Pages
From
From
Gorlin - Syndrome - Pipeline Insight, 2022 - Product Thumbnail Image

Gorlin - Syndrome - Pipeline Insight, 2022

  • Clinical Trials
  • November 2022
  • 60 Pages
From
From
Kaposi Sarcoma: Global Strategic Business Report - Product Thumbnail Image

Kaposi Sarcoma: Global Strategic Business Report

  • Report
  • October 2022
  • 309 Pages
From
Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2022 - Product Thumbnail Image

Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2022

  • Clinical Trials
  • October 2022
  • 60 Pages
From
From
From
Loading Indicator

The Skin Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat skin cancer. These drugs are used to treat a variety of skin cancer types, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The drugs are typically administered orally, intravenously, or topically. The market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Novartis, Pfizer, and Roche. These companies are constantly researching and developing new treatments to improve the efficacy of existing treatments and to develop new treatments for skin cancer. In addition to the major players, there are also many smaller companies that are developing treatments for skin cancer. These companies are often focused on developing treatments for rarer forms of skin cancer, such as Merkel cell carcinoma. Examples of these companies include Aduro Biotech, Arcutis Biotherapeutics, and OncoSec Medical. Show Less Read more